Cargando…
The development prospection of HDAC inhibitors as a potential therapeutic direction in Alzheimer’s disease
Alzheimer’s disease (AD) is a chronic neurodegenerative disease, which is associated with learning and memory impairment in the elderly. Recent studies have found that treating AD in the way of chromatin remodeling via histone acetylation is a promising therapeutic regimen. In a number of recent stu...
Autores principales: | Yang, Shuang-shuang, Zhang, Rui, Wang, Gang, Zhang, Yong-fang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5504819/ https://www.ncbi.nlm.nih.gov/pubmed/28702178 http://dx.doi.org/10.1186/s40035-017-0089-1 |
Ejemplares similares
-
HDAC Inhibitors: Therapeutic Potential in Fibrosis-Associated Human Diseases
por: Yoon, Somy, et al.
Publicado: (2019) -
Development of
HDAC Inhibitors Exhibiting Therapeutic
Potential in T-Cell Prolymphocytic Leukemia
por: Toutah, Krimo, et al.
Publicado: (2021) -
Potential Therapeutic Role of HDAC Inhibitors in FUS-ALS
por: Tejido, Clara, et al.
Publicado: (2021) -
Development of a potential PET probe for HDAC6 imaging in Alzheimer's disease
por: Bai, Ping, et al.
Publicado: (2022) -
Induction of histone deacetylases (HDACs) in human abdominal aortic aneurysm: therapeutic potential of HDAC inhibitors
por: Galán, María, et al.
Publicado: (2016)